Biosimilars Pharmaceutical Companies White Paper 
pharmaphorum
JUNE 29, 2022
She has an extremely wide experience of international pharmaceutical industry issues, consulting to the world’s leading pharmaceutical companies on global issues. She has been vice resident, European Marketing and Thought Leadership in IQVIA for 12 years. the impact of the pandemic on medicines markets and Rx launch.
pharmaphorum
JANUARY 14, 2021
Not so China, and especially not so the lead five European countries – on average European pharmaceutical companies saw a loss of 30% of the interactive time they previously had with healthcare professionals in 2020. Biosimilars accelerate. Focus on customer engagement impact.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 9, 2022
Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceutical companies of international origin within the country. by 2040 based on statistics from OECD. </p> By Tanner Pharma Group.
Pharmaceutical Technology
JANUARY 16, 2023
This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.
Pharmaceutical Technology
JANUARY 16, 2023
This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.
Expert insights. Personalized for you.
59 
Let's personalize your content